TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reduction in Bacteroidetes species
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of decline in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial incremental area under the curve (AUC) of plasma triglyceride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Prevalence of cardiovascular disease (CVD) risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in heart rate during diapering
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Annualized Asthma Exacerbation Rate (AAER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in KAH scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in ICH scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Forced Vital Capacity (FVC(%)predicted)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Diaphragmatic movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Medical Research Council questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Leukocyte ROCK2 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average daily exercise time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum nitric oxide (NO) concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Benefit Rate (CBR) at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of patient-reported data for cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: thirst relief effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in peripheral neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rejection rates of recommendations by caregivers
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Median treatment duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients receiving over 3 months of adjuvant treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: regional flexibility improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from injury to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in communicative and cognitive abilities
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of attendances meeting GP-appropriate problems
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: incidence of grade 3/4 peripheral sensory neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in no-show rates for primary care visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in no-show rates for mental health visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Suicide Probability Scale (SPS) total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three-point reduction in TSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HRV analysis (ANS coordination)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF12 mental score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total Preschool Parental Account of Children's Symptoms score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conduct symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disability Score (DS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: student performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transection blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: final examination score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: student self-assessment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: satisfaction survey
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fluency achievement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-test performance percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of trials to achieve fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instrumented Areas (IA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score during anesthesia induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score during entry of the probe to the rectum and movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain score on penetration of the needle to the prostate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent edema at month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for EBP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: ideal cardiovascular health (CVH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage reduction in monthly migraine attacks from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of responders with ≥30% reduction in monthly migraine attacks from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-minute Apgar's score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: birth satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: bone resorption or formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Discontinuation of MRAs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: % time in range [70‐180 mg/dL]
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: % time >180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of EDs
Endpoint domain: Adverse events/effects
Primary endpoint: urinary cGMP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of complete healing of hard-to-heal ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound pH decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical overall response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3/4 treatment-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Healing rates of ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Time to ulcer healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Incidence of progression to an active ulcer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Instrumentation time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: sPGA 0/1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: analgesic medication consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of treatment group achieving primary outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of surgical success for severe obstructive sleep apnea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: healing of the fissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of antibiotic use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Green space sense and satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Life happiness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dietary habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 90-day functional independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful reperfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: time to death, transplant, or nonelective hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Complete lesion clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean CDLQI score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: nonverbal synchrony
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: phosphate reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: regression of LVMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: regression of CIMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Listening ability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinically relevant non-major bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Absenteeism for any illness
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Absenteeism for acute respiratory illness
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Absenteeism for acute gastrointestinal illness
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mortality rates at 3 and 6 months
Endpoint domain: Mortality/survival
Primary endpoint: clinical or composite endpoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement regarding the need for surgery
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Objective pain scores of the soleus muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delta SARA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Global Impression of Change scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: volume of post-operative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: volume of allogeneic erythrocyte transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Unfavourable outcome
Endpoint domain: Mortality/survival
Primary endpoint: neurodevelopment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Microbiological response (pathogen eradication rates)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Clinical response (cure rates)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body fat-free mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleeping metabolic rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acetylcarnitine concentrations in skeletal muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the diet
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in serum insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Enjoyment of food
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: social aspect
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: cost-per-remitter
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: time to first confirmed decrease in trough FEV1 ≥100 mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: confirmed increase in SGRQ total score ≥4 units
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: moderate/severe exacerbation
Endpoint domain: Adverse events/effects
Primary endpoint: reduction in adolescent PG symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS-pain improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive change evaluation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: OSATS-derived scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived strength of nicotine
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived bad effects of nicotine
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: FEF25–75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Interactive feature use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall feature utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time on site
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participant distress related to lactation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burden of being involved in research
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: favorable functional outcomes at discharge
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: any intracranial hemorrhage (ICH)
Endpoint domain: Adverse events/effects
Primary endpoint: events of moderate-to-severe breakthrough pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean wear rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cup anteversion change within the 1st year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in SUI symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative chest tube drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excessive bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Prostate-Specific Antigen Progression-Free Survival (PSA PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Local Progression-Free Survival (Local PFS)
Endpoint domain: Mortality/survival
Primary endpoint: average gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: health-related quality of life (EuroQol-5 dimension-3L score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: number of patients at risk of malnutrition or malnourished
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mnemonic discrimination performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: information processing speed
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Area under the curve (AUC) for detection of affected ASPECTS region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day composite ACEs
Endpoint domain: Mortality/survival
Primary endpoint: One-year composite ACEs
Endpoint domain: Mortality/survival
Primary endpoint: Median absolute predictive error (PE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in negative interpretations of ambiguous social scenarios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in eating disorder psychopathology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gastrostomy tube complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Predictive accuracy for treatment outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean intubation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: CBDS recurrence rate within 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stool condition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cognitive impairments
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Weight gain over 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increases in fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increases in appendicular lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5MWT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical frailty level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ZIKV neutralizing titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: reintubation at 72 h
Endpoint domain: Mortality/survival
Primary endpoint: self-reported daily dose adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain analogue score decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to self-management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Detection of GG2 or greater cancers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: VAS score (waist and leg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensations of discomfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: acquisition of non-technical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: retention of non-technical skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of OCD measured on the Yale‐Brown Obsessive‐Compulsive Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: motivation to stop substance use
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: motivation to use new needles
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: motivation for clean skin
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Risk of ipsilateral breast events (IBE)
Endpoint domain: Mortality/survival
Primary endpoint: Risk of in situ ipsilateral breast events (DCIS-IBE)
Endpoint domain: Mortality/survival
Primary endpoint: Radiotherapy benefit in preventing DCIS-IBE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: time to clinical deterioration
Endpoint domain: Mortality/survival
Primary endpoint: WORC score change from baseline
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 2-year locoregional control (LRC) rate
Endpoint domain: Mortality/survival
Primary endpoint: Patient's appearance self-evaluation score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean satisfaction score for incision appearance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PASI response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak concentrations of CK‐MB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Peak concentrations of TnT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Increase of CK‐MB to ≥3X upper limit of normal
Endpoint domain: Adverse events/effects
Primary endpoint: risk of appendectomy
Endpoint domain: Mortality/survival
Primary endpoint: resolution of signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inadvertent parathyroidectomy rates
Endpoint domain: Adverse events/effects
Primary endpoint: Increased muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-surgery erythrocyte suspension transfusion number
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: postoperative drain output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean VAS score for spontaneous and cough-induced pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: penile appearance satisfaction rates
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life